Literature DB >> 31329413

CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane Proteins.

Aarti Kawatkar1, Michelle Schefter1, Nils-Olov Hermansson2, Arjan Snijder2, Niek Dekker2, Dean G Brown1, Thomas Lundbäck2, Andrew X Zhang1, M Paola Castaldi1.   

Abstract

Demonstration of target binding is a key requirement for understanding the mode of action of new therapeutics. The cellular thermal shift assay (CETSA) has been introduced as a powerful label-free method to assess target engagement in physiological environments. Here, we present the application of live-cell CETSA to different classes of integral multipass transmembrane proteins using three case studies, the first showing a large and robust stabilization of the outer mitochondrial five-pass transmembrane protein TSPO, the second being a modest stabilization of SERCA2, and the last describing an atypical compound-driven stabilization of the GPCR PAR2. Our data demonstrated that using modified protocols with detergent extraction after the heating step, CETSA can reliably be applied to several membrane proteins of different complexity. By showing examples with distinct CETSA behaviors, we aim to provide the scientific community with an overview of different scenarios to expect during CETSA experiments, especially for challenging, membrane bound targets.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31329413     DOI: 10.1021/acschembio.9b00399

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  15 in total

Review 1.  Current Advances in CETSA.

Authors:  Tuomas Aleksi Tolvanen
Journal:  Front Mol Biosci       Date:  2022-06-09

Review 2.  The emerging role of mass spectrometry-based proteomics in drug discovery.

Authors:  Felix Meissner; Jennifer Geddes-McAlister; Matthias Mann; Marcus Bantscheff
Journal:  Nat Rev Drug Discov       Date:  2022-03-29       Impact factor: 112.288

Review 3.  An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters.

Authors:  Vojtech Dvorak; Tabea Wiedmer; Alvaro Ingles-Prieto; Patrick Altermatt; Helena Batoulis; Felix Bärenz; Eckhard Bender; Daniela Digles; Franz Dürrenberger; Laura H Heitman; Adriaan P IJzerman; Douglas B Kell; Stefanie Kickinger; Daniel Körzö; Philipp Leippe; Thomas Licher; Vania Manolova; Riccardo Rizzetto; Francesca Sassone; Lia Scarabottolo; Avner Schlessinger; Vanessa Schneider; Hubert J Sijben; Anna-Lena Steck; Hanna Sundström; Sara Tremolada; Maria Wilhelm; Marina Wright Muelas; Diana Zindel; Claire M Steppan; Giulio Superti-Furga
Journal:  Front Pharmacol       Date:  2021-08-10       Impact factor: 5.988

Review 4.  Interaction profiling methods to map protein and pathway targets of bioactive ligands.

Authors:  Jun X Huang; John S Coukos; Raymond E Moellering
Journal:  Curr Opin Chem Biol       Date:  2020-03-05       Impact factor: 8.822

Review 5.  Chemoproteomics for Plasmodium Parasite Drug Target Discovery.

Authors:  Kuan-Yi Lu; Christopher R Mansfield; Michael C Fitzgerald; Emily R Derbyshire
Journal:  Chembiochem       Date:  2021-06-10       Impact factor: 3.461

6.  Cell surface thermal proteome profiling tracks perturbations and drug targets on the plasma membrane.

Authors:  Mathias Kalxdorf; Ina Günthner; Isabelle Becher; Nils Kurzawa; Sascha Knecht; Mikhail M Savitski; H Christian Eberl; Marcus Bantscheff
Journal:  Nat Methods       Date:  2021-01-04       Impact factor: 47.990

7.  Capsaicin Targets tNOX (ENOX2) to Inhibit G1 Cyclin/CDK Complex, as Assessed by the Cellular Thermal Shift Assay (CETSA).

Authors:  Atikul Islam; Ally J Su; Zih-Ming Zeng; Pin Ju Chueh; Ming-Hung Lin
Journal:  Cells       Date:  2019-10-18       Impact factor: 6.600

8.  Interaction of Plasmodium falciparum apicortin with α- and β-tubulin is critical for parasite growth and survival.

Authors:  Malabika Chakrabarti; Nishant Joshi; Geeta Kumari; Preeti Singh; Rumaisha Shoaib; Akshay Munjal; Vikash Kumar; Ankita Behl; Mohammad Abid; Swati Garg; Sonal Gupta; Shailja Singh
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

9.  Callyspongiolide kills cells by inducing mitochondrial dysfunction via cellular iron depletion.

Authors:  Jaeyoung Ha; Seung Bum Park
Journal:  Commun Biol       Date:  2021-09-23

10.  Novel Aurora A Kinase Inhibitor Fangchinoline Enhances Cisplatin-DNA Adducts and Cisplatin Therapeutic Efficacy in OVCAR-3 Ovarian Cancer Cells-Derived Xenograft Model.

Authors:  Daniel Winardi; Pei-Yi Chu; Guan-Yu Chen; Ke Wang; Wei-Yu Hsu; Ching-Liang Hsieh; Yung-Hsiang Chen; Yang-Chang Wu; Juan-Cheng Yang
Journal:  Int J Mol Sci       Date:  2022-02-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.